Plain-English translation of NCT06785324 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a combination of nutrition support and gentle exercise can help adults with a type of blood cancer called acute lymphoblastic leukemia (ALL) maintain their muscle strength and body composition during intensive chemotherapy. You would receive personalized guidance on diet and exercise while you're in the hospital for your regular cancer treatment, and you'd wear a fitness tracker to monitor your activity.
Cancer treatment can cause patients to lose muscle mass and experience changes in body composition, which may affect recovery and quality of life. This study aims to see whether nutrition and exercise support during hospitalization can help prevent these losses and support better health outcomes.
You likely qualify if…
You likely don't qualify if…
While you're hospitalized for your regular ALL chemotherapy treatment, you'll work with the study team on nutrition guidance (diet recommendations) and a tailored exercise program suited to your energy level and hospital setting. You'll wear a FitBit activity tracker throughout to record how active you are each day. The study focuses on supporting you during your inpatient treatment without adding extra hospital visits or disrupting your cancer care.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
United States